Published in J Neurosci on September 01, 1994
Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A (2004) 3.87
CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci U S A (2002) 3.32
Antisense oligodeoxynucleotide-mediated disruption of hippocampal cAMP response element binding protein levels impairs consolidation of memory for water maze training. Proc Natl Acad Sci U S A (1997) 2.23
Targeting extinction and reconsolidation mechanisms to combat the impact of drug cues on addiction. Neuropharmacology (2008) 1.84
Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci (1996) 1.59
Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron (1995) 1.56
Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A (2000) 1.30
Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens. Proc Natl Acad Sci U S A (2005) 1.29
Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J Neurochem (2003) 1.29
Maladaptive striatal plasticity in L-DOPA-induced dyskinesia. Prog Brain Res (2010) 1.23
Altered attention and prefrontal cortex gene expression in rats after binge-like exposure to cocaine during adolescence. J Neurosci (2006) 1.22
The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum. Genome Biol (2010) 1.20
Aberrant learning and memory in addiction. Neurobiol Learn Mem (2011) 1.19
cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. J Neurosci (2001) 1.12
CBP in the nucleus accumbens regulates cocaine-induced histone acetylation and is critical for cocaine-associated behaviors. J Neurosci (2011) 1.12
Molecular and genetic substrates linking stress and addiction. Brain Res (2009) 1.11
Galanin protects against behavioral and neurochemical correlates of opiate reward. Neuropsychopharmacology (2007) 1.11
Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity. Biol Psychiatry (2011) 1.10
Chronic methamphetamine exposure suppresses the striatal expression of members of multiple families of immediate early genes (IEGs) in the rat: normalization by an acute methamphetamine injection. Psychopharmacology (Berl) (2011) 1.06
Imaging cerebral gene transcripts in live animals. J Neurosci (2007) 1.02
Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration. CNS Neurol Disord Drug Targets (2010) 0.98
Epigenetic regulation in substance use disorders. Curr Psychiatry Rep (2010) 0.97
Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc Natl Acad Sci U S A (1994) 0.97
Plasticity within striatal direct pathway neurons after neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK 1/2 map kinase pathway. J Comp Neurol (2006) 0.97
Amphetamine-induced locomotion and gene expression are altered in BDNF heterozygous mice. Genes Brain Behav (2008) 0.94
Changes in accumbal and pallidal pCREB and deltaFosB in morphine-sensitized rats: correlations with receptor-evoked electrophysiological measures in the ventral pallidum. Neuropsychopharmacology (2006) 0.93
Forebrain ischemia-reperfusion simulating cardiac arrest in mice induces edema and DNA fragmentation in the brain. Mol Imaging (2007) 0.92
DeltaFosB induction in orbitofrontal cortex potentiates locomotor sensitization despite attenuating the cognitive dysfunction caused by cocaine. Pharmacol Biochem Behav (2008) 0.92
β1-Adrenergic receptors activate two distinct signaling pathways in striatal neurons. J Neurochem (2011) 0.91
Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum. J Neurochem (2003) 0.91
Synaptic and genomic responses to JNK and AP-1 signaling in Drosophila neurons. BMC Neurosci (2005) 0.91
Nitric oxide-soluble guanylyl cyclase signaling regulates corticostriatal transmission and short-term synaptic plasticity of striatal projection neurons recorded in vivo. Neuropharmacology (2009) 0.90
Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice. Brain Res Bull (2010) 0.90
Neuroplasticity in addiction: cellular and transcriptional perspectives. Front Mol Neurosci (2012) 0.88
Protein kinase C-regulated cAMP response element-binding protein phosphorylation in cultured rat striatal neurons. Brain Res Bull (2007) 0.88
Context-specific modulation of cocaine-induced locomotor sensitization and ERK and CREB phosphorylation in the rat nucleus accumbens. Eur J Neurosci (2009) 0.87
Using c-fos to study neuronal ensembles in corticostriatal circuitry of addiction. Brain Res (2014) 0.86
Molecular components of striatal plasticity: the various routes of cyclic AMP pathways. Dev Neurosci (1998) 0.86
It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system. Front Pharmacol (2014) 0.86
Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation. Cold Spring Harb Perspect Med (2013) 0.85
Cocaine increases phosphorylation of MeCP2 in the rat striatum in vivo: a differential role of NMDA receptors. Neurochem Int (2011) 0.83
Anxiety phenotype in mice that overexpress protein kinase A. Psychoneuroendocrinology (2011) 0.83
Protein Kinase A and Anxiety-Related Behaviors: A Mini-Review. Front Endocrinol (Lausanne) (2016) 0.82
Region-dependent dynamics of cAMP response element-binding protein phosphorylation in the basal ganglia. Proc Natl Acad Sci U S A (1998) 0.81
The nuclear transcription factor CREB: involvement in addiction, deletion models and looking forward. Curr Neuropharmacol (2007) 0.80
Adolescent rat circadian activity is modulated by psychostimulants. Brain Res (2011) 0.79
Antipsychotic treatment modulates glutamate transport and NMDA receptor expression. Eur Arch Psychiatry Clin Neurosci (2014) 0.79
Blockade of serotonin 2A receptors prevents PCP-induced attentional performance deficit and CREB phosphorylation in the dorsal striatum of DBA/2 mice. Psychopharmacology (Berl) (2009) 0.79
Inhibiting activator protein-1 activity alters cocaine-induced gene expression and potentiates sensitization. Neuroscience (2008) 0.79
Social defeat stress-induced sensitization and escalated cocaine self-administration: the role of ERK signaling in the rat ventral tegmental area. Psychopharmacology (Berl) (2014) 0.79
L-type Ca2+ channel blockers promote Ca2+ accumulation when dopamine receptors are activated in striatal neurons. Brain Res Mol Brain Res (2004) 0.78
CREB1 and CREB-binding protein in striatal medium spiny neurons regulate behavioural responses to psychostimulants. Psychopharmacology (Berl) (2011) 0.78
Inhibition of cAMP responsive element binding protein in striatal neurons enhances approach and avoidance responses toward morphine--and morphine withdrawal-related cues. Front Behav Neurosci (2009) 0.77
Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice. Psychopharmacology (Berl) (2009) 0.77
Regulation of opioid gene expression in the rat brainstem by 3,4-methylenedioxymethamphetamine (MDMA): role of serotonin and involvement of CREB and ERK cascade. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.76
Calcium-dependent, D2 receptor-independent induction of c-fos by haloperidol in dopamine neurons. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.76
Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation. J Huntingtons Dis (2016) 0.75
CAMKII-conditional deletion of histone deacetylase 2 potentiates acute methamphetamine-induced expression of immediate early genes in the mouse nucleus accumbens. Sci Rep (2015) 0.75
The Epigenetic Mechanisms of Amphetamine. J Addict Prev (2015) 0.75
RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum. Sci Signal (2016) 0.75
Response and habituation of the human amygdala during visual processing of facial expression. Neuron (1996) 5.93
Acute effects of cocaine on human brain activity and emotion. Neuron (1997) 4.88
Addiction, dopamine, and the molecular mechanisms of memory. Neuron (2000) 4.66
Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med (2001) 4.09
Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Infect Immun (1981) 2.94
Exploring the feasibility of a meta-structure for DSM-V and ICD-11: could it improve utility and validity? Psychol Med (2009) 2.93
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science (1998) 2.53
Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc Natl Acad Sci U S A (1992) 2.49
Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity. Infect Immun (1985) 2.47
Proteins bound at adjacent DNA elements act synergistically to regulate human proenkephalin cAMP inducible transcription. EMBO J (1988) 2.15
Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin. Neuron (2001) 1.93
Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci (1996) 1.59
Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron (1995) 1.56
A method for assessing the accuracy of intersubject registration of the human brain using anatomic landmarks. Neuroimage (1999) 1.48
A complex program of striatal gene expression induced by dopaminergic stimulation. J Neurosci (1998) 1.47
Entry of OpaA+ gonococci into HEp-2 cells requires concerted action of glycosaminoglycans, fibronectin and integrin receptors. Mol Microbiol (1998) 1.47
Schizophrenia and cognitive function. Curr Opin Neurobiol (2000) 1.35
Prefrontal regions supporting spontaneous and directed application of verbal learning strategies: evidence from PET. Brain (2001) 1.30
Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci U S A (1992) 1.30
Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biol Psychiatry (2001) 1.23
Neuroimaging of declarative memory in schizophrenia. Scand J Psychol (2001) 1.23
Streptococcal erythrogenic toxin B abrogates fibronectin-dependent internalization of Streptococcus pyogenes by cultured mammalian cells. Infect Immun (2000) 1.14
Cocaine decreases cortical cerebral blood flow but does not obscure regional activation in functional magnetic resonance imaging in human subjects. J Cereb Blood Flow Metab (1998) 1.13
In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein. J Immunol (1991) 1.12
Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis. J Neurosci (1994) 1.12
The effect of depolarization on expression of the human proenkephalin gene is synergistic with cAMP and dependent upon a cAMP-inducible enhancer. J Neurosci (1990) 1.08
The needs for database research and for privacy collide. Am J Psychiatry (2000) 1.07
Intracellular modulation of NMDA receptor function by antipsychotic drugs. J Neurosci (2000) 1.07
Group B streptococcal opacity variants. J Bacteriol (1992) 1.05
Testing models of thalamic dysfunction in schizophrenia using neuroimaging. J Neural Transm (Vienna) (2005) 1.02
The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum. Proc Natl Acad Sci U S A (1993) 1.00
STAT proteins participate in the regulation of the vasoactive intestinal peptide gene by the ciliary neurotrophic factor family of cytokines. Mol Endocrinol (1994) 0.99
Coordinate regulation of choline acetyltransferase, tyrosine hydroxylase, and neuropeptide mRNAs by ciliary neurotrophic factor and leukemia inhibitory factor in cultured sympathetic neurons. J Neurochem (1994) 0.98
Neuroimaging of hallucinations: a review of the literature. Psychiatry Res (1999) 0.98
Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons. J Neurosci (1997) 0.96
Contrasting calcium dependencies of SAPK and ERK activations by glutamate in cultured striatal neurons. J Neurochem (1999) 0.96
Interaction of group B streptococcal opacity variants with the host defense system. Infect Immun (1993) 0.95
An NIMH commentary on the NBAC report. Biol Psychiatry (1999) 0.95
Melorheostosis on three-phase bone scintigraphy. Case report. Clin Nucl Med (1992) 0.95
Introduction to the complex genetics of mental disorders. Biol Psychiatry (1999) 0.90
Haloperidol-induced Fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein. Neuroscience (1995) 0.90
Identification of a functional glucocorticoid response element in the phenylethanolamine N-methyltransferase promoter using fusion genes introduced into chromaffin cells in primary culture. J Neurosci (1990) 0.89
6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Proc Natl Acad Sci U S A (1994) 0.88
Dopamine regulation of transcription factor-target interactions in rat striatum. Chem Senses (1995) 0.87
Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease. J Comp Neurol (1993) 0.86
NIMH symptom challenge and medication discontinuation workshop. Biol Psychiatry (1999) 0.85
Schizophrenia. Med Clin North Am (2001) 0.85
No time for complacency: the fetal brain on drugs. J Comp Neurol (2001) 0.85
Thalamic deactivation during early implicit sequence learning: a functional MRI study. Neuroreport (1998) 0.85
Ciliary neurotrophic factor coordinately activates transcription of neuropeptide genes in a neuroblastoma cell line. Proc Natl Acad Sci U S A (1993) 0.84
An NIMH perspective on the use of placebos. National Institute of Mental Health. Biol Psychiatry (2000) 0.84
Advances in understanding and treating mental illness: implications for policy. Health Aff (Millwood) (1999) 0.84
Cyclic AMP-dependent activation of the proenkephalin gene requires phosphorylation of CREB at serine-133 and a Src-related kinase. J Neurochem (1999) 0.83
Confirmation of reduced temporal limbic structure volume on magnetic resonance imaging in male patients with schizophrenia. Psychiatry Res (1996) 0.83
Mental health in an aging population: the NIMH perspective. Am J Geriatr Psychiatry (2001) 0.83
Analysis of the proenkephalin second messenger-inducible enhancer in rat striatal cultures. J Neurochem (1995) 0.83
Molecular mechanisms of stress-induced proenkephalin gene regulation: CREB interacts with the proenkephalin gene in the mouse hypothalamus and is phosphorylated in response to hyperosmolar stress. Mol Endocrinol (1994) 0.82
Influence of cocaine on the JAK-STAT pathway in the mesolimbic dopamine system. J Neurosci (1996) 0.82
Variations of monoamines and their metabolites in the human brain putamen. Brain Res (1992) 0.82
Postnatal age defines specificity of immediate early gene induction by cocaine in developing rat brain. J Comp Neurol (1995) 0.81
Proenkephalin gene regulation in the neuroendocrine hypothalamus: a model of gene regulation in the CNS. Am J Physiol (1995) 0.81
NIMH during the tenure of Director Steven E. Hyman, M.D. (1996-present): the now and future of NIMH. Am J Psychiatry (1998) 0.81
Retrograde degeneration and colchicine protection of basal forebrain cholinergic neurons following hippocampal injections of an immunotoxin against the P75 nerve growth factor receptor. Neuroscience (1997) 0.80
Localization of mRNA for phenylethanolamine N-methyltransferase (PNMT) using in situ hybridization. Acta Physiol Scand (1987) 0.80
Inhibiting activator protein-1 activity alters cocaine-induced gene expression and potentiates sensitization. Neuroscience (2008) 0.79
Expression and regulation of a proenkephalin beta-galactosidase fusion gene in the reproductive system of transgenic mice. Mol Endocrinol (1992) 0.79
5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine. Synapse (1998) 0.79
Regulation of opioid gene expression: a model to understand neural plasticity. NIDA Res Monogr (1992) 0.79
Cocaine-induced changes in gene expression in rat brain. NIDA Res Monogr (1990) 0.79
A new image for fear and emotion. Nature (1998) 0.79
Mechanisms underlying synaptic regulation of proenkephalin transcription. NIDA Res Monogr (1991) 0.78
Opioids modulate stress-induced proenkephalin gene expression in the hypothalamus of transgenic mice: a model of endogenous opioid gene regulation by exogenous opioids. J Neurosci (1994) 0.78
Substance P phenotype defines specificity of c-fos induction by cocaine in developing rat striatum. J Comp Neurol (1995) 0.78
Cloning and Expression in Escherichia coli of the Polysaccharide Depolymerase Associated with Bacteriophage-Infected Erwinia amylovora. Appl Environ Microbiol (1986) 0.78
Stress-induced regulation of a human proenkephalin-beta-galactosidase fusion gene in the hypothalamus of transgenic mice. Mol Endocrinol (1994) 0.78
How to run a brain bank. A report from the Austro-German brain bank. J Neural Transm Suppl (1993) 0.78
The role of molecular biology in psychiatry. Psychosomatics (1988) 0.77
The case of the pathetic pagetic patella. Clin Nucl Med (1989) 0.76
Adenosine A1 receptors in human hippocampus: inhibition of [3H]8-cyclopentyl-1,3-dipropylxanthine binding by antagonist drugs. Neurosci Lett (1993) 0.76
The ontogeny of immediate early gene response to cocaine: a molecular analysis of the effects of cocaine on developing rat brain. NIDA Res Monogr (1993) 0.76
Murine typhus toxin: studies on identification of the neutralizing factor present in normal human serum. Infect Immun (1972) 0.75
Brain neurocircuitry of anxiety and fear: implications for clinical research and practice. Biol Psychiatry (1998) 0.75
Effect of Trichinella spiralis infection on passive cutaneous anaphylaxis in mice. Infect Immun (1977) 0.75
Plasmid Involvement in Linalool Metabolism by Pseudomonas fluorescens. Appl Environ Microbiol (1986) 0.75
Gallbladder simulating renal fracture during technetium-99m glucoheptonate evaluation for renal trauma. Clin Nucl Med (1986) 0.75
Proenkephalin transgene regulation in the paraventricular nucleus of the hypothalamus by lipopolysaccharide and interleukin-1beta. J Comp Neurol (1999) 0.75
Drug interactions in cocaine abuse: methodologic concerns in human and animal studies. Ann N Y Acad Sci (1998) 0.75
Calcium channel blockers in psychiatry. Psychosomatics (1987) 0.75
Recent developments in neurobiology: Part II. Neurotransmitter receptors and psychopharmacology. Psychosomatics (1988) 0.75
Reactions in the foot pads of mice induced by pertussigen and endotoxin from Bordetella pertussis. J Reticuloendothel Soc (1980) 0.75
Bone and gallium scan findings in malignant fibrous histiocytoma. Case report with radiographic and pathologic correlation. Clin Nucl Med (1987) 0.75
Immunologic cross-reaction between HIV type 1 p17 and Mycoplasma hyorhinis variable lipoprotein. AIDS Res Hum Retroviruses (1998) 0.75
Leukemia inhibitory factor and ciliary neurotrophic factor increase activated Ras in a neuroblastoma cell line and in sympathetic neuron cultures. J Neurochem (1994) 0.75
Recent developments in neurobiology: Part III. Effectors of transmitter action. Psychosomatics (1988) 0.75
Recent developments in neurobiology: Part I. Synaptic transmission. Psychosomatics (1988) 0.75